outperform price
tale decad impress org print
point conservat
take rememb
day appreci impress
 back gfc one
worst organ trajectori lst group
decrement margin reduc earn
spin along grow pain
transform bell highlight
organ revenue print came right alongsid
best class lst peer grew organ feb
march in-line top perform
group
debat scenario given
april arguabl worst month pandem
would put conservat
signal weak turn margin
think decrement like rang
low end like outcom revenue declin trend msd
rang mark improv busi
gfc time lastli think healthi b/ less
net leverag put advantag
posit capit potenti opportun
given rais estim reit
outperform rate new pt equat
price-to-earnings repres premium
guid color market color c/c color
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
rev could
lower end conserv
expect may similar april first week result confirm
feb/march
april
china
expect challeng w/ continu soft
benefit covid though program underway
environment forens
 due univers closur
services/consum gain partial off-set declin instrument
expect continu pressur rest fy
recoveri driven china
must rememb exposur chemic side
expect continu pressur rest fy
feb/march/april look roughli
strength companion dx genom off-set patholog flat weak us patient want stay
america
europ
china april
expect china continu strong rest fy
growth end market besid
acg hsd
covid pt tw provid antibodi pcr micropl test
fx hw
enact cost cut initi focus discretionari spend mostli sg
expect capit spend remaind year
discontinu laserjet project mm yr invest
still remain focus cancer dx biz dont feel need develop sequenc intern
valuat methodolog base mix discount cash flow analysi rel valuat multipl
risk valuat includ regulatori risk overal market risk well unforeseen event relat individu cover
compani broader sector includ new competit product technolog
articl articl
time dissemin may pm et
analyst luke sergott daniel markowitz cindi ding lilli shahidi vijay kumar primarili respons prepar research
report attest follow view opinion render research report reflect person view subject
compani issuer part research analyst compens directli relat specif
recommend view research report
